Marta C. M.
- Country
- Poland
- Department
- Siedleckie Centrum Onkologii
Research Overview
Data & Insights
Has run more than one trial at 0 of 47 partner sites.
Specializations
Oncology Focus
The investigator specializes in the treatment of non-small cell lung cancer (NSCLC), with particular emphasis on advanced and metastatic cases.
- Advanced/Metastatic NSCLC Management
- Immunotherapy Applications
- PD-L1 Expression Studies
Primary interest lies in novel therapeutic approaches for previously untreated lung cancer patients.
Immunotherapy Expertise
The investigator focuses on developing innovative immunotherapy combinations for cancer treatment, with specific attention to pembrolizumab-based therapies.
- Combination Immunotherapy
- First-line Treatment Strategies
- PD-L1 High Expression Tumors
Specialized in evaluating antitumor activity of various immunotherapeutic approaches.
Biomarker Research
Expertise in PD-L1 expression analysis and its implications for treatment selection in lung cancer patients.
- PD-L1 Testing
- Tumor Expression Profiling
- Biomarker-Driven Treatment
Focus on precision medicine approaches using tumor cell and tissue profiling.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
